• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸结合蛋白-7 的过表达与乳腺癌的基底样亚型相关。

Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.

机构信息

Department of Pathology, Tokai University School of Medicine, 143 Shimokasuya, Isehara-City, Kanagawa 259-1193, Japan.

出版信息

Pathol Res Pract. 2010 Feb 15;206(2):98-101. doi: 10.1016/j.prp.2009.06.010. Epub 2009 Jul 15.

DOI:10.1016/j.prp.2009.06.010
PMID:19608352
Abstract

Fatty acid binding protein-7 (FABP-7) is normally expressed in the mammary gland. The aim of this study was to clarify the phenotype of breast cancers with respect to the overexpression of FABP-7. Reverse transcription PCR (RT-PCR) analysis was carried out on 16 cases, including 4 ER(+)/HER2(-), 2 ER(+)/HER2(+), 3 ER(-)/HER2(+), and 5 ER(-)/HER2(-) samples, and 2 non-neoplastic mammary glands as control tissue. Breast cancers categorized as ER(-)/HER2(-) revealed a high cDNA level of FABP-7 as compared to other groups of breast cancer (p=0.004). An immunohistochemical study carried out on 88 cases showed that FABP-7 overexpression had a strong relationship with triple-negative cases (45.8%, p=0.001) and the basal-like subtype (37.5%, p=0.001). Estrogen receptor (ER) and progesterone receptor (PgR) expressions had reverse correlation with FABP-7 overexpression (p=0.003, p<0.0001), but no significant associations can be identified between human epidermal growth factor receptor-2 (HER2) and FABP-7 (p=0.219). In conclusion, this study is the first to demonstrate overexpression of FABP-7 in triple-negative breast cancers [ER(-), PgR(-)/HER2(-)], especially in basal-like breast cancer, and to give a probable interpretation of the high histological grade and poor prognosis of basal-like breast cancer.

摘要

脂肪酸结合蛋白-7(FABP-7)通常在乳腺中表达。本研究旨在阐明 FABP-7 过表达的乳腺癌表型。对包括 4 例 ER(+)/HER2(-)、2 例 ER(+)/HER2(+)、3 例 ER(-)/HER2(+)和 5 例 ER(-)/HER2(-)在内的 16 例病例和 2 例非肿瘤性乳腺组织进行逆转录 PCR(RT-PCR)分析。与其他乳腺癌组相比,归类为 ER(-)/HER2(-)的乳腺癌的 FABP-7 cDNA 水平较高(p=0.004)。对 88 例病例进行的免疫组织化学研究表明,FABP-7 过表达与三阴性病例(45.8%,p=0.001)和基底样亚型(37.5%,p=0.001)具有很强的关系。雌激素受体(ER)和孕激素受体(PgR)的表达与 FABP-7 过表达呈负相关(p=0.003,p<0.0001),但人类表皮生长因子受体-2(HER2)与 FABP-7 之间没有明显的关联(p=0.219)。总之,本研究首次证明 FABP-7 在三阴性乳腺癌(ER(-)、PgR(-)/HER2(-))中过表达,尤其是在基底样乳腺癌中,并且可能解释了基底样乳腺癌的高组织学分级和预后不良。

相似文献

1
Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.脂肪酸结合蛋白-7 的过表达与乳腺癌的基底样亚型相关。
Pathol Res Pract. 2010 Feb 15;206(2):98-101. doi: 10.1016/j.prp.2009.06.010. Epub 2009 Jul 15.
2
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌:大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
3
Comparison of Estrogen receptors, Progesterone receptors and HER2-neu immunohistochemistry results in breast cancer with those of Oncotype Dx.比较乳腺癌雌激素受体、孕激素受体和 HER2-neu 免疫组化结果与 Oncotype Dx 的结果。
Ann Diagn Pathol. 2020 Aug;47:151556. doi: 10.1016/j.anndiagpath.2020.151556. Epub 2020 Jun 20.
4
Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.单激素受体阳性乳腺癌的预后较差:与三阴性乳腺癌的结局相似。
BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4.
5
Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.浸润性导管乳腺癌中基底型细胞角蛋白的免疫组化鉴定——与分级、分期、雌激素受体及人表皮生长因子受体2的关系
Pol J Pathol. 2005;56(3):107-10.
6
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.三阴性表型在接受密集剂量序贯辅助化疗的患者中具有不良预后价值:希腊肿瘤协作组(HeCOG)随机 III 期试验背景下的转化研究分析。
Cancer Chemother Pharmacol. 2012 Feb;69(2):533-46. doi: 10.1007/s00280-011-1730-9. Epub 2011 Sep 8.
7
Is triple negative a prognostic factor in breast cancer?三阴性是乳腺癌的一个预后因素吗?
Breast Cancer. 2008;15(4):303-8. doi: 10.1007/s12282-008-0042-3. Epub 2008 Mar 29.
8
Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.通过生物参数的定量评估对乳腺癌亚型进行特征分析:与临床病理特征、生物学特性及预后的关系
Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2.
9
∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER and HER2 breast cancers.∆Np63/p40与人类雌激素受体(ER)和人表皮生长因子受体2(HER2)阳性乳腺癌中基底/间充质样癌症干细胞的位置和表型相关。
J Pathol Clin Res. 2020 Jan;6(1):83-93. doi: 10.1002/cjp2.149. Epub 2019 Dec 6.
10
Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results.在三阴性乳腺癌中,与 HER2(1+)乳腺癌相比,HER2(0)乳腺癌具有更强的基底样倾向:初步结果。
Breast Cancer. 2012 Jan;19(1):54-9. doi: 10.1007/s12282-011-0265-6. Epub 2011 Apr 5.

引用本文的文献

1
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype.乳腺癌分类器优化了分子乳腺癌分类,以界定HER2低表达亚型。
NPJ Breast Cancer. 2025 Feb 20;11(1):19. doi: 10.1038/s41523-025-00723-0.
2
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.miR-223-3p 在癌症发生发展和癌症药物耐药中的作用:同一枚硬币,两面不同。
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
3
Circ_ZFR affects FABP7 expression to regulate breast cancer progression by acting as a sponge for miR-223-3p.
Circ_ZFR 通过作为 miR-223-3p 的海绵吸附体来影响 FABP7 表达,从而调控乳腺癌的进展。
Thorac Cancer. 2022 May;13(9):1369-1380. doi: 10.1111/1759-7714.14401. Epub 2022 Mar 30.
4
Morphological and pathological features of basal-like breast cancer.基底样乳腺癌的形态学和病理学特征。
Transl Cancer Res. 2019 Oct;8(Suppl 5):S503-S509. doi: 10.21037/tcr.2019.06.50.
5
BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma.脑脂质结合蛋白既是小儿室管膜瘤预后不良的标志物,也是潜在的治疗靶点。
Cancers (Basel). 2021 Apr 27;13(9):2100. doi: 10.3390/cancers13092100.
6
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer.脂肪酸结合蛋白7(FABP7)是预测乳腺癌新辅助化疗反应的潜在生物标志物。
Cancer Cell Int. 2020 Nov 23;20(1):562. doi: 10.1186/s12935-020-01656-3.
7
Metabolic Reprogramming in Triple-Negative Breast Cancer.三阴性乳腺癌中的代谢重编程
Front Oncol. 2020 Mar 31;10:428. doi: 10.3389/fonc.2020.00428. eCollection 2020.
8
Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer.解除细胞色素P450 2C19/环氧二十碳三烯酸相关脂肪酸结合蛋白4/脂肪酸结合蛋白5信号网络的调控作为转移性三阴性乳腺癌的一种治疗方法
Cancers (Basel). 2020 Jan 13;12(1):199. doi: 10.3390/cancers12010199.
9
Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling.脂肪酸结合蛋白 7 在通过 PPAR-α 信号介导三阴性乳腺癌细胞死亡中的代谢作用。
J Lipid Res. 2019 Nov;60(11):1807-1817. doi: 10.1194/jlr.M092379. Epub 2019 Sep 4.
10
Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells.溶质载体家族 27 成员 4(SLC27A4)增强乳腺癌细胞的生长、迁移和侵袭。
Int J Mol Sci. 2018 Nov 1;19(11):3434. doi: 10.3390/ijms19113434.